September 2022 Stock Gainers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2022-09-30, 21 of 21 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of September 2022 Every stock ranked by its September 2022 gain, with or without news

100

Ranked gains

+167.74%

Largest, SPRO

82.8%

Above baseline, day +5

8.0%

Median give-back, day +5

Filter and sort

100 ranked gains in September 2022

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	SPRO More than one ranked move this month 2+ ranked moves	+167.74%	09/22/2022 against the close of 09/21/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr 09/22/2022 02:00 ET premarket	Day +1 +139.75% 2022-09-23 Day +5 +139.75% 2022-09-29 Best close within 5 +154.35% 2022-09-26 16.7% of the move was gone five sessions later. Month end +143.40% on 2022-09-30
Close before and after $0.8217 to $2.20 split-adjusted Session open, high, low $2.04, $3.18, $1.85 Opening gap +148.27% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 218,597,316 shares, $480,914,095 Relative volume 530.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
2	AKRO	+136.76%	09/13/2022 against the close of 09/12/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	In Akero Therapeutics’ Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks 09/13/2022 06:00 ET premarket	Day +1 +125.75% 2022-09-14 Day +5 +114.10% 2022-09-20 Best close within 5 +125.75% 2022-09-14 16.6% of the move was gone five sessions later. Month end +177.51% on 2022-09-30
Close before and after $12.27 to $29.05 as traded Session open, high, low $28.04, $29.78, $25.01 Opening gap +128.52% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 49,698,299 shares, $1,443,735,586 Relative volume 181.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
3	PEPG	+110.19%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy 09/28/2022 06:00 ET premarket	Day +1 +60.77% 2022-09-29 Day +5 +101.35% 2022-10-05 Best close within 5 +101.35% 2022-10-05 8.0% of the move was gone five sessions later. Month end +74.62% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $5.20 to $10.93 split-adjusted Session open, high, low $6.08, $12.84, $5.98 Opening gap +16.92% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 9,989,091 shares, $109,180,765 Relative volume 293.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	LVTX	+97.50%	09/26/2022 against the close of 09/23/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, a Preclinical Gamma Delta Bispecific T Cell Engager for EGFR-Expressing Solid Tumors 09/26/2022 08:00 ET premarket	Day +1 +88.75% 2022-09-27 Day +5 +70.00% 2022-10-03 Best close within 5 +97.92% 2022-09-28 28.2% of the move was gone five sessions later. Month end +90.42% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $2.40 to $4.74 as traded Session open, high, low $5.51, $5.67, $4.38 Opening gap +129.58% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 44,648,013 shares, $211,631,582 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
5	BEAT under $25M today More than one ranked move this month 2+ ranked moves	+85.60%	09/15/2022 against the close of 09/14/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias 09/15/2022 08:31 ET premarket	Day +1 +52.80% 2022-09-16 Day +5 +52.80% 2022-09-22 Best close within 5 +58.40% 2022-09-19 38.3% of the move was gone five sessions later. Month end +212.00% on 2022-09-30
Close before and after $1.25 to $2.32 split-adjusted Session open, high, low $1.97, $2.45, $1.90 Opening gap +57.60% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 114,305,300 shares, $265,188,296 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	SLNG	+73.67%	09/21/2022 against the close of 09/20/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Stabilis Solutions Receives DOE Approval to Export LNG 09/21/2022 08:00 ET premarket	Day +1 +58.15% 2022-09-22 Day +5 +30.06% 2022-09-28 Best close within 5 +58.15% 2022-09-22 59.2% of the move was gone five sessions later. Month end +52.06% on 2022-09-30
Close before and after $5.09 to $8.84 split-adjusted Session open, high, low $5.75, $12.32, $5.29 Opening gap +12.97% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 21,320,395 shares, $188,472,292 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	DMS	+71.88%	09/09/2022 against the close of 09/08/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	DMS Receives Non-Binding “Go Private” Proposal 09/08/2022 16:15 ET after hours	Day +1 +73.44% 2022-09-12 Day +5 +51.56% 2022-09-16 Best close within 5 +73.44% 2022-09-12 28.3% of the move was gone five sessions later. Month end +50.00% on 2022-09-30
Close before and after $19.20 to $33.00 as traded Session open, high, low $29.40, $35.70, $27.75 Opening gap +53.13% Close inside the session range 0.66 of the range, where 1.00 is the high Session volume 3,768,893 shares, $124,373,469 Relative volume 496.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	INM under $25M today Also on the opposite board this month on both boards	+70.42%	09/12/2022 against the close of 09/09/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market 09/09/2022 17:00 ET after hours	Day +1 +9.53% 2022-09-13 Day +5 -29.22% 2022-09-19 Best close within 5 +9.53% 2022-09-13 It gave back the whole move and closed 29.22% below the pre-news price. Month end -40.17% on 2022-09-30
Close before and after $220.40 to $375.60 split-adjusted Session open, high, low $300.00, $390.00, $275.60 Opening gap +36.12% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 1,596,873 shares, $599,785,499 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
9	ISEE	+66.31%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Iveric Bio Announces Positive Topline Data from Zimura® GATHER2 Phase 3 Clinical Trial in Geographic Atrophy 09/06/2022 06:00 ET premarket	Day +1 +58.26% 2022-09-07 Day +5 +92.69% 2022-09-13 Best close within 5 +96.93% 2022-09-09 Five sessions later the move was 39.8% bigger, at +92.69%. Month end +90.04% on 2022-09-30
Close before and after $9.44 to $15.70 as traded Session open, high, low $12.96, $15.94, $12.28 Opening gap +37.29% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 128,694,659 shares, $2,020,506,146 Relative volume 62.6x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
10	BTRS	+60.83%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Billtrust to be Acquired by EQT Private Equity for Equity Value of $1.7 Billion 09/28/2022 09:00 ET premarket	Day +1 +60.83% 2022-09-29 Day +5 +61.18% 2022-10-05 Best close within 5 +61.18% 2022-10-05 Five sessions later the move was 0.6% bigger, at +61.18%. Month end +60.49% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $5.77 to $9.28 as traded Session open, high, low $9.30, $9.30, $9.19 Opening gap +61.18% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 74,021,059 shares, $686,915,428 Relative volume 109.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	PYPD Also on the opposite board this month on both boards	+58.33%	09/12/2022 against the close of 09/09/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	PolyPid Announces Presentation of Phase 2 D-PLEX₁₀₀ Clinical Data at the European Society for Coloproctology Scientific Conference 09/12/2022 07:00 ET premarket	Day +1 +28.70% 2022-09-13 Day +5 +18.52% 2022-09-19 Best close within 5 +28.70% 2022-09-13 68.2% of the move was gone five sessions later. Month end +8.33% on 2022-09-30
Close before and after $32.40 to $51.30 split-adjusted Session open, high, low $34.20, $66.00, $32.40 Opening gap +5.56% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 1,339,596 shares, $68,721,275 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
12	SPRO More than one ranked move this month 2+ ranked moves	+55.50%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration 09/06/2022 08:05 ET premarket	Day +1 +96.78% 2022-09-07 Day +5 +43.11% 2022-09-13 Best close within 5 +96.78% 2022-09-07 22.3% of the move was gone five sessions later. Month end +175.22% on 2022-09-30
Close before and after $0.7267 to $1.13 split-adjusted Session open, high, low $0.8353, $1.90, $0.8000 Opening gap +14.94% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 80,518,325 shares, $90,985,707 Relative volume 492.3x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
13	ECOM	+55.03%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	CommerceHub to Acquire ChannelAdvisor for $23.10 per share 09/06/2022 07:30 ET premarket	Day +1 +54.90% 2022-09-07 Day +5 +55.51% 2022-09-13 Best close within 5 +55.92% 2022-09-09 Five sessions later the move was 0.9% bigger, at +55.51%. Month end +54.15% on 2022-09-30
Close before and after $14.70 to $22.79 as traded Session open, high, low $22.78, $22.84, $22.71 Opening gap +54.97% Close inside the session range 0.62 of the range, where 1.00 is the high Session volume 7,544,195 shares, $171,932,204 Relative volume 51.5x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
14	FMTX	+51.04%	09/01/2022 against the close of 08/31/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders 09/01/2022 08:00 ET premarket	Day +1 +49.10% 2022-09-02 Day +5 +48.66% 2022-09-09 Best close within 5 +49.10% 2022-09-02 4.7% of the move was gone five sessions later. Month end +48.88% on 2022-09-30
Close before and after $13.40 to $20.24 as traded Session open, high, low $19.83, $20.28, $19.77 Opening gap +47.99% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 43,800,304 shares, $886,518,153 Relative volume 147.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	AMLX Also on the opposite board this month on both boards	+51.01%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS 09/07/2022 19:45 ET after hours	Day +1 +66.93% 2022-09-09 Day +5 +72.40% 2022-09-15 Best close within 5 +72.40% 2022-09-15 Five sessions later the move was 41.9% bigger, at +72.40%. Month end +57.26% on 2022-09-30
Close before and after $17.90 to $27.03 split-adjusted Session open, high, low $31.30, $32.80, $27.00 Opening gap +74.86% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 13,102,101 shares, $354,149,790 Relative volume 22.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	AAOI	+50.40%	09/16/2022 against the close of 09/15/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Applied Optoelectronics Announces Definitive Agreement to Sell its Chinese Manufacturing Facilities and Certain Assets Related to its Transceiver Business for $150 Million 09/15/2022 16:10 ET after hours Applied Optoelectronics, Inc. Launches Quantum Bandwidth™ 09/16/2022	Day +1 +46.40% 2022-09-19 Day +5 +14.00% 2022-09-23 Best close within 5 +46.40% 2022-09-19 72.2% of the move was gone five sessions later. Month end +8.80% on 2022-09-30
Close before and after $2.50 to $3.76 split-adjusted Session open, high, low $3.01, $3.94, $2.87 Opening gap +20.40% Close inside the session range 0.83 of the range, where 1.00 is the high Session volume 77,414,189 shares, $291,077,351 Relative volume 383.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
17	NRBO under $25M today	+47.21%	09/15/2022 against the close of 09/14/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies 09/15/2022 08:30 ET premarket	Day +1 +6.29% 2022-09-16 Day +5 -1.48% 2022-09-22 Best close within 5 +23.31% 2022-09-20 It gave back the whole move and closed 1.48% below the pre-news price. Month end -18.80% on 2022-09-30
Close before and after $134.88 to $198.56 as traded Session open, high, low $219.04, $239.04, $176.48 Opening gap +62.40% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 1,021,545 shares, $202,837,975 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	XFOR	+40.18%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	X4 Pharmaceuticals Announces New Positive Phase 1b Data Supporting Mavorixafor’s Broad Potential in Chronic Neutropenia (CN) 09/27/2022 07:50 ET premarket	Day +1 +62.61% 2022-09-28 Day +5 +106.35% 2022-10-04 Best close within 5 +106.35% 2022-10-04 Five sessions later the move was 164.7% bigger, at +106.35%. Month end +91.77% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $26.75 to $37.50 split-adjusted Session open, high, low $31.50, $38.40, $27.30 Opening gap +17.75% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 314,596 shares, $11,797,350 Relative volume 17.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	BIIB	+39.85%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE 09/27/2022 19:30 ET after hours	Day +1 +33.62% 2022-09-29 Day +5 +32.31% 2022-10-05 Best close within 5 +35.22% 2022-10-04 18.9% of the move was gone five sessions later. Month end +34.99% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $197.79 to $276.61 split-adjusted Session open, high, low $282.96, $283.44, $265.02 Opening gap +43.06% Close inside the session range 0.63 of the range, where 1.00 is the high Session volume 16,191,526 shares, $4,478,738,007 Relative volume 17.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	PRPL under $25M today More than one ranked move this month 2+ ranked moves	+39.43%	09/19/2022 against the close of 09/16/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Purple Innovation Confirms Receipt of Unsolicited, Non-Binding Proposal to Acquire the Company 09/19/2022 07:19 ET premarket	Day +1 +41.22% 2022-09-20 Day +5 +39.43% 2022-09-26 Best close within 5 +46.24% 2022-09-21 0.0% of the move was gone five sessions later. Month end +45.16% on 2022-09-30
Close before and after $69.75 to $97.25 split-adjusted Session open, high, low $99.00, $103.25, $93.00 Opening gap +41.94% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 2,654,577 shares, $258,157,613 Relative volume 64.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
21	ATHX	+39.32%	09/23/2022 against the close of 09/22/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Athersys Amends Securities Purchase Agreement in Connection with Recent Registered Direct Offering 09/23/2022 09:19 ET premarket	Day +1 +21.37% 2022-09-26 Day +5 +58.12% 2022-09-30 Best close within 5 +58.12% 2022-09-30 Five sessions later the move was 47.8% bigger, at +58.12%. Month end +58.12% on 2022-09-30
Close before and after $1.17 to $1.63 as traded Session open, high, low $1.16, $2.10, $1.16 Opening gap -0.85% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 40,327,746 shares, $65,734,226 Relative volume 38.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	LITM Also on the opposite board this month on both boards	+38.26%	09/23/2022 against the close of 09/22/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Snow Lake Lithium and LG Energy Solution Collaborate To Establish Lithium Supply Chain in North America 09/23/2022 06:00 ET premarket	Day +1 -18.26% 2022-09-26 Day +5 -23.48% 2022-09-30 Best close within 5 -18.26% 2022-09-26 It gave back the whole move and closed 23.48% below the pre-news price. Month end -23.48% on 2022-09-30
Close before and after $29.90 to $41.34 as traded Session open, high, low $36.27, $46.15, $33.54 Opening gap +21.30% Close inside the session range 0.62 of the range, where 1.00 is the high Session volume 5,662,972 shares, $234,107,262 Relative volume 362.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
23	AEHL under $25M today Also on the opposite board this month on both boards	+37.46%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Antelope Enterprise Schedules First Half 2022 Earnings Conference Call 09/27/2022 09:00 ET premarket	Day +1 +41.56% 2022-09-28 Day +5 -14.75% 2022-10-04 Best close within 5 +41.56% 2022-09-28 It gave back the whole move and closed 14.75% below the pre-news price. Month end -7.73% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $26,035.20 to $35,788.80 split-adjusted Session open, high, low $31,150.08, $38,400.00, $28,293.12 Opening gap +19.65% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 119 shares, $4,258,867 Baseline gap 1 calendar day from the pre-news close to the measured session
24	AIMD under $25M today	+36.96%	09/30/2022 against the close of 09/29/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Ainos Announces Positive Results from Additional Preclinical Study of Its Low-dose Oral Interferon Formulation Against New Variant Virus - Omicron 09/30/2022 07:00 ET premarket	Day +1 +38.41% 2022-10-03 Day +5 +15.94% 2022-10-07 Best close within 5 +38.41% 2022-10-03 56.9% of the move was gone five sessions later. Month end +36.96% on 2022-09-30 same session This month ended before the fifth session after the move.
Close before and after $34.50 to $47.25 split-adjusted Session open, high, low $50.50, $58.75, $44.25 Opening gap +46.38% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 1,403,822 shares, $66,330,590 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	GROV	+35.47%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Grove Co. Continues Retail Expansion with Entry Into Thousands of More Stores 09/27/2022 08:31 ET premarket	Day +1 +2.36% 2022-09-28 Day +5 -22.30% 2022-10-04 Best close within 5 +2.36% 2022-09-28 It gave back the whole move and closed 22.30% below the pre-news price. Month end -24.32% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $14.80 to $20.05 split-adjusted Session open, high, low $16.30, $22.40, $15.50 Opening gap +10.14% Close inside the session range 0.66 of the range, where 1.00 is the high Session volume 1,367,816 shares, $27,424,711 Relative volume 46.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	CO	+34.58%	09/23/2022 against the close of 09/22/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation 09/23/2022 13:52 ET intraday	Day +1 no data Day +5 no data Best close within 5 no data Month-end is not shown: no closing price is available for 2022-09-30.
Close before and after $2.22 to $2.99 as traded Session open, high, low $2.21, $3.32, $2.21 Opening gap -0.45% Close inside the session range 0.70 of the range, where 1.00 is the high Session volume 9,284,888 shares, $27,739,531 Relative volume 76.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	MRKR under $25M today	+31.50%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Marker Therapeutics to Participate in Cantor Fitzgerald Cell and Genetic Medicines Conference 09/08/2022 07:00 ET premarket	Day +1 +47.98% 2022-09-09 Day +5 +50.77% 2022-09-15 Best close within 5 +57.81% 2022-09-13 Five sessions later the move was 61.2% bigger, at +50.77%. Month end +21.28% on 2022-09-30
Close before and after $3.04 to $4.00 split-adjusted Session open, high, low $3.19, $4.80, $3.00 Opening gap +4.87% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 1,059,790 shares, $4,238,100 Relative volume 26.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
28	IDYA	+30.70%	09/12/2022 against the close of 09/09/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	IDEAYA Reports Positive Interim Phase 2 Clinical Results for Darovasertib and Crizotinib Synthetic Lethal Combination in Metastatic Uveal Melanoma 09/11/2022 17:00 ET after hours	Day +1 +35.35% 2022-09-13 Day +5 +28.86% 2022-09-19 Best close within 5 +35.35% 2022-09-13 6.0% of the move was gone five sessions later. Month end +61.30% on 2022-09-30
Close before and after $9.25 to $12.09 split-adjusted Session open, high, low $10.20, $12.28, $9.78 Opening gap +10.27% Close inside the session range 0.92 of the range, where 1.00 is the high Session volume 2,543,810 shares, $30,754,663 Relative volume 8.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
29	CLVS	+30.43%	09/12/2022 against the close of 09/09/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups 09/11/2022 10:30 ET intraday	Day +1 +29.57% 2022-09-13 Day +5 +6.96% 2022-09-19 Best close within 5 +29.57% 2022-09-13 77.1% of the move was gone five sessions later. Month end +3.48% on 2022-09-30
Close before and after $1.15 to $1.50 as traded Session open, high, low $1.28, $1.59, $1.24 Opening gap +11.30% Close inside the session range 0.75 of the range, where 1.00 is the high Session volume 32,769,188 shares, $49,153,782 Relative volume 17.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
30	KLXE	+30.28%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	KLX Energy Services Announces Amendment and Extension of ABL Facility 09/28/2022 08:00 ET premarket	Day +1 +35.70% 2022-09-29 Day +5 +91.78% 2022-10-05 Best close within 5 +91.78% 2022-10-05 Five sessions later the move was 203.1% bigger, at +91.78%. Month end +53.83% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $5.35 to $6.97 split-adjusted Session open, high, low $5.50, $7.38, $5.50 Opening gap +2.80% Close inside the session range 0.78 of the range, where 1.00 is the high Session volume 821,667 shares, $5,727,019 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	BBAI	+30.25%	09/29/2022 against the close of 09/28/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	BigBear.ai Awarded $14.8 Million U.S. Army Global Force Information Management System Contract 09/29/2022 08:00 ET premarket	Day +1 +31.93% 2022-09-30 Day +5 +25.21% 2022-10-06 Best close within 5 +51.26% 2022-10-05 16.7% of the move was gone five sessions later. Month end +31.93% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $1.19 to $1.55 split-adjusted Session open, high, low $1.61, $1.80, $1.47 Opening gap +35.29% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 54,725,510 shares, $84,824,541 Relative volume 435.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	OIIM	+30.15%	09/30/2022 against the close of 09/29/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	O2Micro Enters into Definitive Agreement for “Going Private” Transaction 09/30/2022 09:35 ET intraday	Day +1 +31.69% 2022-10-03 Day +5 +33.23% 2022-10-07 Best close within 5 +34.46% 2022-10-04 Five sessions later the move was 10.2% bigger, at +33.23%. Month end +30.15% on 2022-09-30 same session This month ended before the fifth session after the move.
Close before and after $3.25 to $4.23 as traded Session open, high, low $3.22, $4.31, $3.22 Opening gap -0.92% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 1,812,490 shares, $7,666,833 Relative volume 54.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	SONX	+30.08%	09/23/2022 against the close of 09/22/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Sonendo, Inc. Announces $63 Million Private Placement 09/23/2022 07:00 ET premarket	Day +1 +28.98% 2022-09-26 Day +5 +17.96% 2022-09-30 Best close within 5 +84.10% 2022-09-27 40.3% of the move was gone five sessions later. Month end +17.96% on 2022-09-30
Close before and after $181.42 to $236.00 split-adjusted Session open, high, low $252.00, $252.00, $196.10 Opening gap +38.90% Close inside the session range 0.71 of the range, where 1.00 is the high Session volume 86,723 shares, $20,466,628 Relative volume 177.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	MOGU under $25M today	+29.82%	09/09/2022 against the close of 09/08/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	MOGU Inc. Announces US$10 Million Share Repurchase Program 09/09/2022 07:00 ET premarket	Day +1 +17.84% 2022-09-12 Day +5 +5.36% 2022-09-16 Best close within 5 +30.82% 2022-09-13 82.0% of the move was gone five sessions later. Month end +17.34% on 2022-09-30
Close before and after $2.00 to $2.60 split-adjusted Session open, high, low $2.81, $2.95, $2.38 Opening gap +40.31% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 22,905,840 shares, $59,555,184 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	GRTX under $25M today	+29.46%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Galera to Participate in the H.C. Wainwright 24th Annual Global Investment Conference 09/06/2022 07:00 ET premarket	Day +1 +39.53% 2022-09-07 Day +5 +40.31% 2022-09-13 Best close within 5 +62.79% 2022-09-08 Five sessions later the move was 36.8% bigger, at +40.31%. Month end +34.88% on 2022-09-30
Close before and after $258.00 to $334.00 as traded Session open, high, low $264.00, $346.00, $263.20 Opening gap +2.33% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 3,202 shares, $1,069,468 Relative volume 15.6x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
36	NTNX	+29.13%	09/01/2022 against the close of 08/31/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Nutanix Reports Fourth Quarter and Fiscal 2022 Financial Results 08/31/2022 16:05 ET after hours	Day +1 +25.72% 2022-09-02 Day +5 +33.41% 2022-09-09 Best close within 5 +33.41% 2022-09-09 Five sessions later the move was 14.7% bigger, at +33.41%. Month end +20.40% on 2022-09-30
Close before and after $17.30 to $22.34 split-adjusted Session open, high, low $20.99, $22.94, $20.98 Opening gap +21.33% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 21,271,047 shares, $475,195,190 Relative volume 12.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	KNBE	+28.15%	09/19/2022 against the close of 09/16/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	KnowBe4 Confirms Receipt of Non-Binding Proposal from Vista Equity Partners 09/19/2022 09:20 ET premarket	Day +1 +27.17% 2022-09-20 Day +5 +22.14% 2022-09-26 Best close within 5 +27.17% 2022-09-20 21.3% of the move was gone five sessions later. Month end +20.29% on 2022-09-30
Close before and after $17.30 to $22.17 as traded Session open, high, low $21.66, $22.83, $21.40 Opening gap +25.20% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 9,458,049 shares, $209,684,946 Relative volume 18.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
38	AKUS	+28.00%	09/13/2022 against the close of 09/12/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Akouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing Loss 09/13/2022 07:00 ET premarket	Day +1 +28.00% 2022-09-14 Day +5 +36.86% 2022-09-20 Best close within 5 +47.43% 2022-09-16 Five sessions later the move was 31.6% bigger, at +36.86%. Month end +93.14% on 2022-09-30
Close before and after $3.50 to $4.48 as traded Session open, high, low $3.75, $4.80, $3.15 Opening gap +7.14% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 335,305 shares, $1,502,166 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	BEAT under $25M today More than one ranked move this month 2+ ranked moves	+27.88%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG) 09/28/2022 08:31 ET premarket	Day +1 +55.39% 2022-09-29 Day +5 +68.40% 2022-10-05 Best close within 5 +68.40% 2022-10-05 Five sessions later the move was 145.3% bigger, at +68.40%. Month end +44.98% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $2.69 to $3.44 split-adjusted Session open, high, low $2.89, $3.99, $2.75 Opening gap +7.43% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 8,898,880 shares, $30,612,147 Relative volume 117.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	HROW More than one ranked move this month 2+ ranked moves	+27.86%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia 09/27/2022 13:50 ET intraday	Day +1 +30.22% 2022-09-28 Day +5 +55.19% 2022-10-04 Best close within 5 +68.46% 2022-10-03 Five sessions later the move was 98.1% bigger, at +55.19%. Month end +58.61% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $7.61 to $9.73 split-adjusted Session open, high, low $7.71, $10.50, $7.57 Opening gap +1.31% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 1,897,715 shares, $18,464,767 Relative volume 22.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
41	ALLK	+27.51%	09/19/2022 against the close of 09/16/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock 09/19/2022 07:00 ET premarket	Day +1 +21.18% 2022-09-20 Day +5 +22.27% 2022-09-26 Best close within 5 +22.27% 2022-09-26 19.0% of the move was gone five sessions later. Month end +33.62% on 2022-09-30
Close before and after $4.58 to $5.84 as traded Session open, high, low $5.34, $6.13, $5.20 Opening gap +16.59% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 21,801,726 shares, $127,322,080 Relative volume 18.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
42	SPRO More than one ranked move this month 2+ ranked moves	+26.55%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Spero Therapeutics to Present at Upcoming Investor Conference 09/07/2022 08:05 ET premarket	Day +1 +7.96% 2022-09-08 Day +5 -18.22% 2022-09-14 Best close within 5 +7.96% 2022-09-08 It gave back the whole move and closed 18.22% below the pre-news price. Month end +76.99% on 2022-09-30
Close before and after $1.13 to $1.43 split-adjusted Session open, high, low $1.24, $1.50, $1.18 Opening gap +9.73% Close inside the session range 0.78 of the range, where 1.00 is the high Session volume 57,822,930 shares, $82,686,790 Relative volume 421.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	PTN under $25M today	+26.20%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Palatin Announces Initiation of Patient Recruitment for Phase 2 Clinical Study Evaluating Oral PL8177 for Treatment of Ulcerative Colitis 09/08/2022 07:30 ET premarket	Day +1 +35.60% 2022-09-09 Day +5 +34.60% 2022-09-15 Best close within 5 +56.00% 2022-09-12 Five sessions later the move was 32.1% bigger, at +34.60%. Month end +18.40% on 2022-09-30
Close before and after $5.00 to $6.31 split-adjusted Session open, high, low $4.95, $6.42, $4.95 Opening gap -1.00% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 555,566 shares, $3,505,621 Relative volume 7.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	AVCO	+25.85%	09/29/2022 against the close of 09/28/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Avalon GloboCare Receives Allowance for Joint U.S. Patent 09/29/2022 09:00 ET premarket	Day +1 +14.44% 2022-09-30 Day +5 -19.66% 2022-10-06 Best close within 5 +14.44% 2022-09-30 It gave back the whole move and closed 19.66% below the pre-news price. Month end +14.44% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $0.5601 to $0.7049 as traded Session open, high, low $0.5600, $0.7099, $0.5600 Opening gap -0.02% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 472,757 shares, $333,246 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
45	LFST	+25.76%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	LifeStance Health Appoints Ken Burdick as CEO and Chairman; Founding CEO and Chairman Michael Lester Retires 09/08/2022 09:00 ET premarket	Day +1 +21.29% 2022-09-09 Day +5 +17.87% 2022-09-15 Best close within 5 +21.29% 2022-09-09 30.6% of the move was gone five sessions later. Month end -13.01% on 2022-09-30
Close before and after $7.61 to $9.57 split-adjusted Session open, high, low $7.54, $10.50, $7.47 Opening gap -0.92% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 6,753,531 shares, $64,631,292 Relative volume 22.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	ASAN More than one ranked move this month 2+ ranked moves	+24.79%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Asana Announces $350 Million Private Placement 09/07/2022 16:05 ET after hours Asana Announces Record Second Quarter Fiscal 2023 Revenues 09/07/2022	Day +1 +29.52% 2022-09-09 Day +5 +34.24% 2022-09-15 Best close within 5 +50.79% 2022-09-12 Five sessions later the move was 38.1% bigger, at +34.24%. Month end +16.75% on 2022-09-30
Close before and after $19.04 to $23.76 split-adjusted Session open, high, low $22.55, $24.80, $21.42 Opening gap +18.43% Close inside the session range 0.69 of the range, where 1.00 is the high Session volume 27,790,190 shares, $660,294,914 Relative volume 11.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	TWIN	+24.62%	09/01/2022 against the close of 08/31/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Twin Disc, Inc. Announces Fiscal 2022 Fourth Quarter Financial Results 09/01/2022 08:00 ET premarket	Day +1 +27.85% 2022-09-02 Day +5 +48.17% 2022-09-09 Best close within 5 +48.17% 2022-09-09 Five sessions later the move was 95.7% bigger, at +48.17%. Month end +23.33% on 2022-09-30
Close before and after $9.30 to $11.59 split-adjusted Session open, high, low $11.15, $11.59, $10.53 Opening gap +19.89% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 54,285 shares, $629,163 Relative volume 7.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	AKA	+23.73%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	a.k.a. Brands Holding Corp. Announces Participation in the Piper Sandler Growth Frontiers Conference 09/07/2022 08:00 ET premarket	Day +1 0.00% 2022-09-08 Day +5 -24.15% 2022-09-14 Best close within 5 0.00% 2022-09-08 It gave back the whole move and closed 24.15% below the pre-news price. Month end -38.56% on 2022-09-30
Close before and after $28.32 to $35.04 split-adjusted Session open, high, low $29.88, $35.40, $27.00 Opening gap +5.51% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 89,829 shares, $3,147,608 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
49	EQ	+22.80%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Equillium Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis 09/27/2022 07:00 ET premarket	Day +1 +15.54% 2022-09-28 Day +5 +3.63% 2022-10-04 Best close within 5 +18.65% 2022-09-29 84.1% of the move was gone five sessions later. Month end +15.03% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $1.93 to $2.37 split-adjusted Session open, high, low $2.23, $2.55, $2.16 Opening gap +15.54% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 11,213,906 shares, $26,576,957 Relative volume 452.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	EVAX	+22.63%	09/21/2022 against the close of 09/20/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Important Milestone Reached for Evaxion Biotech’s EVX-01 Personalized Cancer Therapy 09/21/2022 05:45 ET premarket	Day +1 +27.89% 2022-09-22 Day +5 +45.79% 2022-09-28 Best close within 5 +53.16% 2022-09-23 Five sessions later the move was 102.3% bigger, at +45.79%. Month end +38.42% on 2022-09-30
Close before and after $95.00 to $116.50 split-adjusted Session open, high, low $162.50, $176.00, $107.50 Opening gap +71.05% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 924,047 shares, $107,651,476 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	SVRE under $25M today	+22.40%	09/20/2022 against the close of 09/19/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Strauss Frito-Lay Chooses the SaverOne Protection System for its Delivery Trucks in Israel 09/20/2022 08:45 ET premarket	Day +1 +3.13% 2022-09-21 Day +5 -15.10% 2022-09-27 Best close within 5 +3.13% 2022-09-21 It gave back the whole move and closed 15.10% below the pre-news price. Month end -21.35% on 2022-09-30
Close before and after $16,584.65 to $20,298.92 split-adjusted Session open, high, low $17,534.82, $20,903.57, $16,584.65 Opening gap +5.73% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 162 shares, $3,288,426 Relative volume 10.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	AVTX	+22.29%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Avalo Advances BTLA Agonist Fusion Protein (AVTX-008) to IND-enabling Stage 09/06/2022 07:00 ET premarket	Day +1 +3.96% 2022-09-07 Day +5 -7.71% 2022-09-13 Best close within 5 +3.96% 2022-09-07 It gave back the whole move and closed 7.71% below the pre-news price. Month end -30.83% on 2022-09-30
Close before and after $1,152.00 to $1,408.80 split-adjusted Session open, high, low $1,178.40, $1,435.20, $1,156.80 Opening gap +2.29% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 485 shares, $683,268 Relative volume 3.9x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
53	INNV	+21.98%	09/14/2022 against the close of 09/13/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	InnovAge Announces Financial Results for the Fiscal Year and Fourth Quarter Ended June 30, 2022 09/13/2022 16:05 ET after hours	Day +1 +26.42% 2022-09-15 Day +5 +50.37% 2022-09-21 Best close within 5 +54.32% 2022-09-19 Five sessions later the move was 129.2% bigger, at +50.37%. Month end +45.19% on 2022-09-30
Close before and after $4.05 to $4.94 split-adjusted Session open, high, low $4.08, $4.97, $3.75 Opening gap +0.74% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 1,136,352 shares, $5,613,579 Relative volume 12.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	ZS	+21.88%	09/09/2022 against the close of 09/08/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Zscaler Reports Fourth Quarter and Fiscal 2022 Financial Results 09/08/2022 16:05 ET after hours Zscaler Achieves Carbon Neutral Status and Establishes New Goal to Reach Net Zero by 2025 09/08/2022	Day +1 +25.51% 2022-09-12 Day +5 +9.88% 2022-09-16 Best close within 5 +25.51% 2022-09-12 54.8% of the move was gone five sessions later. Month end +6.56% on 2022-09-30
Close before and after $154.25 to $188.00 split-adjusted Session open, high, low $174.95, $188.79, $173.09 Opening gap +13.42% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 11,412,463 shares, $2,145,543,044 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	RVNC	+21.58%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results 09/08/2022 07:00 ET premarket	Day +1 +36.81% 2022-09-09 Day +5 +26.91% 2022-09-15 Best close within 5 +36.81% 2022-09-09 Five sessions later the move was 24.7% bigger, at +26.91%. Month end +29.75% on 2022-09-30
Close before and after $20.81 to $25.30 as traded Session open, high, low $24.72, $25.47, $22.02 Opening gap +18.79% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 8,902,093 shares, $225,222,953 Relative volume 11.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	BEAT under $25M today More than one ranked move this month 2+ ranked moves	+21.51%	09/29/2022 against the close of 09/28/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	HeartBeam to Present at Upcoming Investor Conferences 09/29/2022 08:31 ET premarket	Day +1 +13.37% 2022-09-30 Day +5 +66.57% 2022-10-06 Best close within 5 +66.57% 2022-10-06 Five sessions later the move was 209.5% bigger, at +66.57%. Month end +13.37% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $3.44 to $4.18 split-adjusted Session open, high, low $3.50, $4.72, $3.23 Opening gap +1.74% Close inside the session range 0.64 of the range, where 1.00 is the high Session volume 14,827,082 shares, $61,977,203 Relative volume 141.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	INPX	+21.50%	09/26/2022 against the close of 09/23/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	Inpixon's Enterprise Apps Business to be Acquired in a Business Combination Transaction Valued at $69 Million 09/26/2022 09:30 ET intraday	Day +1 +11.83% 2022-09-27 Day +5 +6.48% 2022-10-03 Best close within 5 +11.83% 2022-09-27 69.9% of the move was gone five sessions later. Month end +6.22% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $868.50 to $1,055.25 as traded Session open, high, low $1,335.00, $1,335.00, $911.25 Opening gap +53.71% Close inside the session range 0.34 of the range, where 1.00 is the high Session volume 3,404 shares, $3,592,071 Relative volume 21.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
58	SGRP under $25M today	+21.26%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	SPAR Group, Inc. Announces Review of Strategic Alternatives 09/08/2022 08:00 ET premarket	Day +1 +20.47% 2022-09-09 Day +5 +17.32% 2022-09-15 Best close within 5 +20.47% 2022-09-09 18.5% of the move was gone five sessions later. Month end +14.17% on 2022-09-30
Close before and after $1.27 to $1.54 split-adjusted Session open, high, low $1.35, $1.63, $1.35 Opening gap +6.30% Close inside the session range 0.68 of the range, where 1.00 is the high Session volume 945,098 shares, $1,455,451 Relative volume 86.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	FUSN	+21.09%	09/14/2022 against the close of 09/13/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 09/13/2022 16:45 ET after hours	Day +1 +7.14% 2022-09-15 Day +5 +6.80% 2022-09-21 Best close within 5 +11.56% 2022-09-19 67.8% of the move was gone five sessions later. Month end +2.38% on 2022-09-30
Close before and after $2.94 to $3.56 as traded Session open, high, low $2.95, $3.70, $2.95 Opening gap +0.34% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 2,286,414 shares, $8,139,634 Relative volume 34.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	RETA	+21.06%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference 09/06/2022 16:51 ET after hours	Day +1 +21.06% 2022-09-08 Day +5 +29.29% 2022-09-14 Best close within 5 +29.29% 2022-09-14 Five sessions later the move was 39.1% bigger, at +29.29%. Month end +12.39% on 2022-09-30
Close before and after $22.36 to $27.07 as traded Session open, high, low $22.20, $27.82, $22.20 Opening gap -0.72% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 5,282,453 shares, $142,996,003 Relative volume 6.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	VNET	+20.68%	09/13/2022 against the close of 09/12/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	VNET Announces Receipt of Preliminary Non-Binding Proposal to Acquire All of Its Shares and Formation of Special Committee to Review the Proposal 09/13/2022 08:39 ET premarket	Day +1 +29.85% 2022-09-14 Day +5 +32.41% 2022-09-20 Best close within 5 +33.26% 2022-09-19 Five sessions later the move was 56.7% bigger, at +32.41%. Month end +17.27% on 2022-09-30
Close before and after $4.69 to $5.66 split-adjusted Session open, high, low $5.42, $6.29, $5.23 Opening gap +15.57% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 12,755,311 shares, $72,195,060 Relative volume 20.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	JUPW	+20.53%	09/29/2022 against the close of 09/28/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Jupiter Wellness Announces Application for Dual Listing on Upstream 09/29/2022 08:30 ET premarket	Day +1 +28.18% 2022-09-30 Day +5 +26.23% 2022-10-06 Best close within 5 +28.18% 2022-09-30 Five sessions later the move was 27.8% bigger, at +26.23%. Month end +28.18% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $0.6085 to $0.7334 split-adjusted Session open, high, low $0.6290, $0.7738, $0.6200 Opening gap +3.37% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 561,674 shares, $411,932 Relative volume 2.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	PRPL under $25M today More than one ranked move this month 2+ ranked moves	+20.28%	09/01/2022 against the close of 08/31/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Purple Innovation Acquires Intellibed 09/01/2022 08:30 ET premarket Purple Innovation Announces Acquisition of Intellibed 09/01/2022	Day +1 +8.74% 2022-09-02 Day +5 +8.04% 2022-09-09 Best close within 5 +8.74% 2022-09-02 60.4% of the move was gone five sessions later. Month end +41.61% on 2022-09-30
Close before and after $71.50 to $86.00 split-adjusted Session open, high, low $69.75, $86.50, $67.25 Opening gap -2.45% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 125,656 shares, $10,806,416 Relative volume 2.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	FRBK	+20.08%	09/15/2022 against the close of 09/14/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	REPUBLIC FIRST BANCORP, INC. ANNOUNCES STRATEGIC REVIEW 09/15/2022 09:00 ET premarket	Day +1 +19.69% 2022-09-16 Day +5 +14.29% 2022-09-22 Best close within 5 +24.71% 2022-09-19 28.8% of the move was gone five sessions later. Month end +9.27% on 2022-09-30
Close before and after $2.59 to $3.11 as traded Session open, high, low $2.72, $3.18, $2.69 Opening gap +5.02% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 1,137,822 shares, $3,538,626 Relative volume 4.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	EVEX Also on the opposite board this month on both boards	+19.97%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	United Invests Another $15 Million in Electric Flying Taxi Market with Eve 09/08/2022 07:00 ET premarket	Day +1 +25.16% 2022-09-09 Day +5 +72.56% 2022-09-15 Best close within 5 +72.56% 2022-09-15 Five sessions later the move was 263.3% bigger, at +72.56%. Month end +50.00% on 2022-09-30
Close before and after $6.16 to $7.39 split-adjusted Session open, high, low $7.38, $7.49, $6.65 Opening gap +19.81% Close inside the session range 0.88 of the range, where 1.00 is the high Session volume 185,509 shares, $1,370,912 Relative volume 4.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	STOR	+19.90%	09/15/2022 against the close of 09/14/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	STORE Capital to be Acquired by GIC and Oak Street in $14 Billion Transaction 09/15/2022 08:00 ET premarket	Day +1 +19.07% 2022-09-16 Day +5 +18.40% 2022-09-22 Best close within 5 +19.26% 2022-09-19 7.5% of the move was gone five sessions later. Month end +16.95% on 2022-09-30
Close before and after $26.79 to $32.12 as traded Session open, high, low $32.34, $32.36, $32.06 Opening gap +20.72% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 57,727,021 shares, $1,854,191,915 Relative volume 30.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	PNT Also on the opposite board this month on both boards	+19.84%	09/12/2022 against the close of 09/09/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022 09/10/2022 03:05 ET premarket	Day +1 +18.67% 2022-09-13 Day +5 +1.05% 2022-09-19 Best close within 5 +18.67% 2022-09-13 94.7% of the move was gone five sessions later. Month end -9.80% on 2022-09-30
Close before and after $8.57 to $10.27 as traded Session open, high, low $9.74, $10.98, $9.38 Opening gap +13.65% Close inside the session range 0.56 of the range, where 1.00 is the high Session volume 2,921,595 shares, $30,004,781 Relative volume 5.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
68	ALR	+19.82%	09/19/2022 against the close of 09/16/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	AlerisLife Announces the Appointment of Heather Pereira as Senior Vice President, Chief Financial Officer and Treasurer 09/19/2022 08:05 ET premarket	Day +1 +3.60% 2022-09-20 Day +5 -10.81% 2022-09-26 Best close within 5 +3.60% 2022-09-20 It gave back the whole move and closed 10.81% below the pre-news price. Month end -14.42% on 2022-09-30
Close before and after $1.11 to $1.33 as traded Session open, high, low $1.09, $1.58, $1.06 Opening gap -1.80% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 2,401,020 shares, $3,193,357 Relative volume 88.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
69	TRT	+19.61%	09/23/2022 against the close of 09/22/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Trio-Tech Reports Fiscal 2022 Net Income of $0.57 Per Share Versus a Loss of $0.15 Per Share as Revenue Increased 36% 09/23/2022 08:30 ET premarket	Day +1 +16.07% 2022-09-26 Day +5 +13.73% 2022-09-30 Best close within 5 +18.87% 2022-09-29 30.0% of the move was gone five sessions later. Month end +13.73% on 2022-09-30
Close before and after $2.04 to $2.44 split-adjusted Session open, high, low $2.25, $2.54, $2.22 Opening gap +10.29% Close inside the session range 0.70 of the range, where 1.00 is the high Session volume 304,590 shares, $743,200 Relative volume 18.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	HOWL	+19.57%	09/01/2022 against the close of 08/31/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1/1b Clinical Trial of WTX-124 for the Treatment of Patients with Selected Solid Tumors 09/01/2022 07:00 ET premarket	Day +1 +36.96% 2022-09-02 Day +5 +46.64% 2022-09-09 Best close within 5 +46.64% 2022-09-09 Five sessions later the move was 138.3% bigger, at +46.64%. Month end -10.87% on 2022-09-30
Close before and after $5.06 to $6.05 split-adjusted Session open, high, low $4.98, $6.33, $4.90 Opening gap -1.58% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 97,721 shares, $591,212 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
71	AMRS	+19.56%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES 09/07/2022 08:00 ET premarket	Day +1 +32.84% 2022-09-08 Day +5 +44.65% 2022-09-14 Best close within 5 +49.45% 2022-09-13 Five sessions later the move was 128.3% bigger, at +44.65%. Month end +7.75% on 2022-09-30
Close before and after $2.71 to $3.24 as traded Session open, high, low $2.72, $3.25, $2.68 Opening gap +0.37% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 7,281,644 shares, $23,592,527 Relative volume 0.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	EPM	+19.44%	09/14/2022 against the close of 09/13/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	Evolution Petroleum Reports Fourth Quarter and Full Year Fiscal 2022 Results, Declares Increased Quarterly Cash Dividend for First Quarter Fiscal 2023, and Announces $25 Million Share Repurchase Program 09/13/2022 16:15 ET after hours	Day +1 +17.97% 2022-09-15 Day +5 +13.40% 2022-09-21 Best close within 5 +25.63% 2022-09-19 31.1% of the move was gone five sessions later. Month end +2.50% on 2022-09-30
Close before and after $6.79 to $8.11 split-adjusted Session open, high, low $7.15, $8.27, $7.15 Opening gap +5.30% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 1,276,936 shares, $10,355,951 Relative volume 5.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	AURA	+19.23%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Aura Biosciences Announces First Patient Dosed in Phase 1 Study Evaluating Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer 09/28/2022 07:00 ET premarket	Day +1 +12.02% 2022-09-29 Day +5 -9.68% 2022-10-05 Best close within 5 +17.74% 2022-09-30 It gave back the whole move and closed 9.68% below the pre-news price. Month end +17.74% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $15.39 to $18.35 split-adjusted Session open, high, low $15.50, $19.18, $15.40 Opening gap +0.71% Close inside the session range 0.78 of the range, where 1.00 is the high Session volume 208,687 shares, $3,829,406 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	TUP under $25M today	+19.16%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Tupperware Names Douglas Lane as Vice President of Investor Relations and Strategy 09/06/2022 16:37 ET after hours	Day +1 +20.79% 2022-09-08 Day +5 +26.77% 2022-09-14 Best close within 5 +40.35% 2022-09-12 Five sessions later the move was 39.7% bigger, at +26.77%. Month end -11.01% on 2022-09-30
Close before and after $7.36 to $8.77 as traded Session open, high, low $7.31, $8.81, $7.22 Opening gap -0.68% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 4,762,428 shares, $41,766,494 Relative volume 7.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	REGN	+18.85%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, with a Vast Majority of Patients Maintained on 12- and 16-week Dosing Intervals 09/08/2022 09:00 ET premarket Dupixent® (dupilumab) Late-breaking Phase 3 Data at the EADV 2022 Congress Showed Significant Improvements in Signs and Symptoms of Prurigo Nodularis 09/08/2022	Day +1 +21.44% 2022-09-09 Day +5 +18.34% 2022-09-15 Best close within 5 +21.44% 2022-09-09 2.7% of the move was gone five sessions later. Month end +15.50% on 2022-09-30
Close before and after $596.44 to $708.85 split-adjusted Session open, high, low $686.99, $718.96, $652.64 Opening gap +15.18% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 3,731,457 shares, $2,645,043,294 Relative volume 8.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	GKOS	+18.52%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles 09/07/2022 07:00 ET premarket	Day +1 +21.37% 2022-09-08 Day +5 +18.15% 2022-09-14 Best close within 5 +21.60% 2022-09-12 2.0% of the move was gone five sessions later. Month end +10.69% on 2022-09-30
Close before and after $48.10 to $57.01 split-adjusted Session open, high, low $52.76, $60.92, $51.49 Opening gap +9.69% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 4,560,572 shares, $259,998,210 Relative volume 11.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	BLPH	+18.43%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease 09/27/2022 08:30 ET premarket	Day +1 +15.31% 2022-09-28 Day +5 +17.39% 2022-10-04 Best close within 5 +18.43% 2022-10-03 5.6% of the move was gone five sessions later. Month end +13.23% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $0.9626 to $1.14 as traded Session open, high, low $1.29, $1.30, $1.10 Opening gap +34.01% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 279,329 shares, $318,435 Relative volume 27.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
78	VTGN under $25M today	+18.36%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Vistagen to Proceed with PALISADE-2 Phase 3 Clinical Trial of PH94B in Social Anxiety Disorder following Interim Analysis 09/08/2022 08:00 ET premarket	Day +1 +25.27% 2022-09-09 Day +5 +16.18% 2022-09-15 Best close within 5 +25.27% 2022-09-09 11.9% of the move was gone five sessions later. Month end -7.82% on 2022-09-30
Close before and after $4.95 to $5.86 split-adjusted Session open, high, low $5.17, $7.12, $5.01 Opening gap +4.42% Close inside the session range 0.40 of the range, where 1.00 is the high Session volume 2,225,481 shares, $13,039,093 Relative volume 6.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	PALI	+18.33%	09/13/2022 against the close of 09/12/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Palisade Bio to Present at the Virtual Investor Innovations in Intestinal Health - Launching a Pivotal Phase 3 Study for Return of Postoperative Bowel Function Event 09/13/2022 09:05 ET premarket	Day +1 +9.63% 2022-09-14 Day +5 -17.00% 2022-09-20 Best close within 5 +9.63% 2022-09-14 It gave back the whole move and closed 17.00% below the pre-news price. Month end -34.26% on 2022-09-30
Close before and after $112.95 to $133.65 split-adjusted Session open, high, low $111.38, $133.95, $106.13 Opening gap -1.39% Close inside the session range 0.99 of the range, where 1.00 is the high Session volume 21,032 shares, $2,810,927 Relative volume 1.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	PLSE	+18.30%	09/26/2022 against the close of 09/23/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia 09/26/2022 08:00 ET premarket	Day +1 +5.88% 2022-09-27 Day +5 +44.44% 2022-10-03 Best close within 5 +50.33% 2022-09-30 Five sessions later the move was 142.8% bigger, at +44.44%. Month end +50.33% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $1.53 to $1.81 split-adjusted Session open, high, low $1.73, $2.20, $1.60 Opening gap +13.07% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 4,339,736 shares, $7,854,922 Relative volume 66.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
81	DYN	+18.25%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Dyne Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference 09/06/2022 16:30 ET after hours	Day +1 +27.59% 2022-09-08 Day +5 +23.22% 2022-09-14 Best close within 5 +29.99% 2022-09-12 Five sessions later the move was 27.2% bigger, at +23.22%. Month end +8.83% on 2022-09-30
Close before and after $11.67 to $13.80 split-adjusted Session open, high, low $11.67, $14.46, $11.66 Opening gap 0.00% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 905,297 shares, $12,493,099 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	CYTH	+18.02%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Cyclo Therapeutics Provides Business Update 09/28/2022 14:02 ET intraday	Day +1 +13.95% 2022-09-29 Day +5 +23.84% 2022-10-05 Best close within 5 +23.84% 2022-10-05 Five sessions later the move was 32.3% bigger, at +23.84%. Month end +12.21% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $1.72 to $2.03 as traded Session open, high, low $1.80, $2.13, $1.76 Opening gap +4.65% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 220,306 shares, $447,221 Relative volume 15.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	COUP	+17.91%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Coupa Software Reports Second Quarter Fiscal 2023 Financial Results 09/06/2022 16:03 ET after hours	Day +1 +21.98% 2022-09-08 Day +5 +25.31% 2022-09-14 Best close within 5 +31.82% 2022-09-12 Five sessions later the move was 41.3% bigger, at +25.31%. Month end +5.34% on 2022-09-30
Close before and after $55.82 to $65.82 as traded Session open, high, low $62.88, $66.15, $61.00 Opening gap +12.65% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 15,384,667 shares, $1,012,618,782 Relative volume 11.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	CVV	+17.58%	09/28/2022 against the close of 09/27/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	CVD Equipment Corporation Announces Sale and Leaseback Agreement 09/27/2022 16:05 ET after hours	Day +1 +14.29% 2022-09-29 Day +5 +17.36% 2022-10-05 Best close within 5 +21.98% 2022-10-04 1.3% of the move was gone five sessions later. Month end +14.29% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $4.55 to $5.35 split-adjusted Session open, high, low $4.74, $5.39, $4.66 Opening gap +4.18% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 56,497 shares, $302,259 Relative volume 5.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	NUVL	+17.55%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Nuvalent to Present Preliminary Phase 1 Data from ARROS-1 Clinical Trial of NVL-520 at 34th EORTC-NCI-AACR Symposium and Announces Pipeline Updates 09/07/2022 06:30 ET premarket	Day +1 +14.10% 2022-09-08 Day +5 +23.40% 2022-09-14 Best close within 5 +25.20% 2022-09-12 Five sessions later the move was 33.3% bigger, at +23.40%. Month end +29.26% on 2022-09-30
Close before and after $15.04 to $17.68 as traded Session open, high, low $14.97, $18.07, $14.97 Opening gap -0.47% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 254,311 shares, $4,496,218 Relative volume 2.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	CDE	+17.54%	09/19/2022 against the close of 09/16/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Coeur Announces Agreement to Sell Southern Nevada Holdings for Upfront Cash Consideration of $150 million 09/19/2022 06:50 ET premarket	Day +1 +9.12% 2022-09-20 Day +5 -5.26% 2022-09-26 Best close within 5 +9.12% 2022-09-20 It gave back the whole move and closed 5.26% below the pre-news price. Month end +20.00% on 2022-09-30
Close before and after $2.85 to $3.35 split-adjusted Session open, high, low $2.80, $3.38, $2.78 Opening gap -1.75% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 13,482,797 shares, $45,167,370 Relative volume 3.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
87	CPTN	+17.42%	09/21/2022 against the close of 09/20/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology 09/21/2022 12:13 ET intraday	Day +1 -5.06% 2022-09-22 Day +5 +6.18% 2022-09-28 Best close within 5 +6.18% 2022-09-28 64.5% of the move was gone five sessions later. Month end +10.11% on 2022-09-30
Close before and after $17.80 to $20.90 as traded Session open, high, low $17.50, $25.90, $17.30 Opening gap -1.69% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 3,124,112 shares, $65,293,941 Relative volume 96.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	SHCR	+17.37%	09/19/2022 against the close of 09/16/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Sharecare awarded three-year NCQA Accreditation for Wellness and Health Promotion 09/19/2022 07:30 ET premarket	Day +1 +18.56% 2022-09-20 Day +5 +9.58% 2022-09-26 Best close within 5 +23.35% 2022-09-21 44.8% of the move was gone five sessions later. Month end +13.77% on 2022-09-30
Close before and after $1.67 to $1.96 as traded Session open, high, low $1.65, $2.01, $1.64 Opening gap -1.20% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 3,517,340 shares, $6,893,986 Relative volume 1.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
89	USEA	+17.36%	09/02/2022 against the close of 09/01/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Buyback / Dividend	United Announces $3 million Share Buyback Plan 09/02/2022 09:00 ET premarket	Day +1 +23.14% 2022-09-06 Day +5 +38.84% 2022-09-12 Best close within 5 +48.76% 2022-09-08 Five sessions later the move was 123.7% bigger, at +38.84%. Month end +42.98% on 2022-09-30
Close before and after $1.21 to $1.42 split-adjusted Session open, high, low $1.50, $1.60, $1.37 Opening gap +23.97% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 19,305,182 shares, $27,413,358 Relative volume 26.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	AMPS Also on the opposite board this month on both boards	+17.10%	09/27/2022 against the close of 09/26/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Altus Power, Inc. Announces Definitive Agreements to Acquire Approximately 97 Megawatts of Operating Solar Assets 09/27/2022 07:37 ET premarket	Day +1 +19.88% 2022-09-28 Day +5 -0.67% 2022-10-04 Best close within 5 +19.88% 2022-09-28 It gave back the whole move and closed 0.67% below the pre-news price. Month end -7.25% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $11.87 to $13.90 as traded Session open, high, low $12.24, $14.00, $12.10 Opening gap +3.12% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 3,539,017 shares, $49,192,336 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	MCRB	+17.04%	09/07/2022 against the close of 09/06/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Seres Therapeutics Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection 09/07/2022 07:00 ET premarket	Day +1 +24.26% 2022-09-08 Day +5 +33.33% 2022-09-14 Best close within 5 +33.33% 2022-09-14 Five sessions later the move was 95.6% bigger, at +33.33%. Month end +18.89% on 2022-09-30
Close before and after $108.00 to $126.40 split-adjusted Session open, high, low $109.80, $127.30, $108.70 Opening gap +1.67% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 104,258 shares, $13,178,211 Relative volume 3.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	FHS	+16.95%	09/08/2022 against the close of 09/07/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	First High-School Education Group Announces First Half 2022 Unaudited Financial Results 09/08/2022 07:30 ET premarket	Day +1 +24.75% 2022-09-09 Day +5 +26.70% 2022-09-15 Best close within 5 +36.44% 2022-09-12 Five sessions later the move was 57.5% bigger, at +26.70%. Month end -6.28% on 2022-09-30
Close before and after $0.6413 to $0.7500 as traded Session open, high, low $0.6530, $0.7599, $0.6530 Opening gap +1.82% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 838,519 shares, $628,889 Relative volume 10.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	NYC under $25M today	+16.62%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	NYC Advisor and Its Affiliates Express Confidence in NYC REIT With $2.5 Million Share Purchase, Stock Election 09/06/2022 06:00 ET premarket	Day +1 +17.78% 2022-09-07 Day +5 +20.41% 2022-09-13 Best close within 5 +22.74% 2022-09-12 Five sessions later the move was 22.8% bigger, at +20.41%. Month end -5.83% on 2022-09-30
Close before and after $27.44 to $32.00 split-adjusted Session open, high, low $29.52, $33.08, $27.36 Opening gap +7.58% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 12,190 shares, $390,080 Relative volume 2.7x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
94	TC	+16.61%	09/30/2022 against the close of 09/29/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	TuanChe Announces Unaudited First Half 2022 Financial Results 09/29/2022 17:00 ET after hours TuanChe to Hold 2022 Annual General Meeting on November 4, 2022 09/30/2022	Day +1 +31.27% 2022-10-03 Day +5 +59.28% 2022-10-07 Best close within 5 +74.27% 2022-10-06 Five sessions later the move was 256.9% bigger, at +59.28%. Month end +16.61% on 2022-09-30 same session This month ended before the fifth session after the move.
Close before and after $921.00 to $1,074.00 split-adjusted Session open, high, low $900.00, $1,074.00, $897.00 Opening gap -2.28% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 328 shares, $352,272 Relative volume 1.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	ASAN More than one ranked move this month 2+ ranked moves	+16.42%	09/12/2022 against the close of 09/09/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Asana to Present at Upcoming Investor Events 09/09/2022 16:05 ET after hours	Day +1 +3.08% 2022-09-13 Day +5 +2.84% 2022-09-19 Best close within 5 +3.65% 2022-09-15 82.7% of the move was gone five sessions later. Month end -9.85% on 2022-09-30
Close before and after $24.66 to $28.71 split-adjusted Session open, high, low $25.29, $28.92, $25.21 Opening gap +2.55% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 9,906,659 shares, $284,420,180 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
96	ADT	+16.37%	09/06/2022 against the close of 09/02/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	ADT Announces Partnership With State Farm, Plans Innovative Offering That Combines Security, Risk Mitigation and Smart Home Capabilities to Revolutionize the Customer Experience 09/06/2022 08:30 ET premarket	Day +1 +16.64% 2022-09-07 Day +5 +16.23% 2022-09-13 Best close within 5 +20.11% 2022-09-12 0.9% of the move was gone five sessions later. Month end +3.88% on 2022-09-30
Close before and after $7.21 to $8.39 split-adjusted Session open, high, low $8.09, $8.42, $7.91 Opening gap +12.21% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 14,817,752 shares, $124,320,939 Relative volume 11.1x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
97	HROW More than one ranked move this month 2+ ranked moves	+16.25%	09/29/2022 against the close of 09/28/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	ImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin 5%) Compounded Antibiotic Formulation 09/29/2022 07:00 ET premarket	Day +1 +21.80% 2022-09-30 Day +5 +20.18% 2022-10-06 Best close within 5 +29.36% 2022-10-03 Five sessions later the move was 24.2% bigger, at +20.18%. Month end +21.80% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $9.91 to $11.52 split-adjusted Session open, high, low $9.87, $11.62, $9.87 Opening gap -0.40% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 677,387 shares, $7,803,498 Relative volume 7.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	SONN under $25M today	+16.15%	09/26/2022 against the close of 09/23/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Sonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee 09/26/2022 08:00 ET premarket	Day +1 +1.24% 2022-09-27 Day +5 -8.07% 2022-10-03 Best close within 5 +1.24% 2022-09-27 It gave back the whole move and closed 8.07% below the pre-news price. Month end -8.70% on 2022-09-30 This month ended before the fifth session after the move.
Close before and after $283.36 to $329.12 as traded Session open, high, low $265.76, $334.40, $264.00 Opening gap -6.21% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 3,223 shares, $1,060,754 Relative volume 12.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
99	ATIF under $25M today	+15.70%	09/15/2022 against the close of 09/14/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	ATIF Holdings Limited President of Investment Ian Zhiliang Zhou Names 2022 Forbes China Global 100 Outstanding Chinese 09/15/2022 08:05 ET premarket	Day +1 +15.16% 2022-09-16 Day +5 -2.90% 2022-09-22 Best close within 5 +15.16% 2022-09-16 It gave back the whole move and closed 2.90% below the pre-news price. Month end -8.13% on 2022-09-30
Close before and after $1.72 to $1.99 as traded Session open, high, low $2.08, $2.08, $1.86 Opening gap +20.94% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 56,744 shares, $112,921 Relative volume 8.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
100	MSGM under $25M today	+15.68%	09/09/2022 against the close of 09/08/2022 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Motorsport Games to Participate in the H.C. Wainwright 24th Annual Global Investment Conference 09/09/2022 09:00 ET premarket	Day +1 +4.48% 2022-09-12 Day +5 +29.49% 2022-09-16 Best close within 5 +38.53% 2022-09-13 Five sessions later the move was 88.1% bigger, at +29.49%. Month end -18.59% on 2022-09-30
Close before and after $7.00 to $8.10 split-adjusted Session open, high, low $7.40, $8.78, $7.03 Opening gap +5.68% Close inside the session range 0.61 of the range, where 1.00 is the high Session volume 26,742 shares, $216,610 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 226 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

2 events were left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

1 event was left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In September 2022, the median gainer had given back 8.0% of its move five sessions later; the largest catalyst group was Other Announcement, 33 of the 100 events, at a median of +22.4%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still above the pre-news close at day +5
Other Announcement	33	33.0%	+22.4%	+23.5% of 32	75.0% of 32
Clinical Trial Results	20	20.0%	+28.3%	+21.0%	90.0% of 20
M&A / Acquisition	11	11.0%	+21.3%	+18.4%	81.8% of 11
Earnings	9	9.0%	Fewer than 10 events in this group, so no figures are shown.
FDA & Regulatory	7	7.0%	Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 20 events: Contract / Partnership, Offering / Dilution, Leadership Change, Buyback / Dividend, Reverse Merger / Shell.

How much of the move survived

Horizon	Still above the pre-news close close to close	Median change since the measured close as a share of the move
Day +1	97.0% of 99	3.5% given back, of 99
Day +5	82.8% of 99	8.0% given back, of 99
Month end	77.1% of 96	30.2% given back, of 96
Month end falls before day +5 for 24 of these 96 events, so this row is not a later horizon than the one above it. 96 of the 100 events have a month-end close later than the measured session; 3 have it on the measured session itself, and 1 has no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside September 2022

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Best move
SPRO	3Contract / Partnership, Other Announcement	+167.74%
BEAT	3Other Announcement	+85.60%
PRPL	2M&A / Acquisition	+39.43%
HROW	2FDA & Regulatory, Other Announcement	+27.86%
ASAN	2Offering / Dilution, Other Announcement	+24.79%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Best move
RGS	2022-08, 2022-06	+75.15%
KTRA	2022-08, 2022-06	+38.26%
TUPthis month too	2022-08, 2022-07	+32.36%
RMO	2022-08, 2022-06	+30.82%
WTRH	2022-08, 2022-07	+48.49%
GROVthis month too	2022-07, 2022-06	+84.25%
TRHC	2022-07, 2022-06	+56.54%
TNXP	2022-07, 2022-06	+45.38%
KRBP	2022-07, 2022-06	+79.22%
SIDU	2022-07, 2022-06	+225.00%
QD	2022-07, 2022-06	+40.34%
TANH	2022-07, 2022-06	+23.12%
OCFT	2022-07, 2022-06	+21.21%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

1 event has too little trading history for a relative volume, and is not in the tiers above.

Industry

19 other industries, 22 events

Industry not known: 33.0%

Against August 2022

100 events in the comparable window.

August 2022 median +36.1%, selected from the 10,507 events in that month's eligible pool

September 2022 median +22.5%, 13.6 points below August 2022. September 2022's median is taken over the 100 ranked rows, selected from the 8,285 events in that month's eligible pool.

The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.